NAHRI’s 2018 Revenue Integrity Symposium is fast approaching, and I am very much looking forward to what’s in store—both at the conference and in the Phoenix area where I reside. Phoenix is truly a beautiful area and the Revenue Integrity Symposium allows you to take in all it has to offer during one of the most beautiful times of year.
This week's note from the instructor reviews some of the major proposals in the 2019 Outpatient Prospective Payment System (OPPS) proposed rule and examines the impact these proposals may have on health systems.
It’s been one year since the National Association of Healthcare Revenue Integrity welcomed its first member and we are now more than 700 members strong. That’s more than 700 driven, dedicated individuals from across the country who have joined forces to ensure the revenue integrity profession is recognized for its unique contributions to the healthcare field.
In the 2019 OPPS proposed rule, CMS does not introduce a new skin substitute payment policy but is seeking comment on potential changes for future rulemaking.
Along with quality measure removals in the 2018 OPPS and MPFS final rules, CMS has continued to propose additional removals in the 2019 proposed rules. In addition, the agency is proposing to add to its ability to remove quality measures in the future.
CMS’ 2019 OPPS proposed rule, released in late July, continues the agency’s efforts to enforce site-neutral payments and reduce drug payments by introducing policies to reduce reimbursement for hospital outpatient clinic visits at off-campus, provider-based departments.
